CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Percutaneous Coronary Revascularization for STEMIWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (3)


Name (Synonyms) Correlation
D000072657 ST Elevation Myocardial Infarction NIH 0.71
D007238 Infarction NIH 0.50
D009203 Myocardial Ischemia NIH 0.35

Correlated HPO Terms (1)


Name (Synonyms) Correlation
HP:0001658 Myocardial infarction HPO 0.35

There is one clinical trial.

Clinical Trials


1 International Study on Acute Coronary Syndromes - ST-segment Elevation Myocardial Infarction COVID 19

The ISACS STEMI COVID-19 has been established in response to the emerging outbreak of COVID-19 to provide a European overview to estimate the real impact of COVID-19 pandemic on treatment and outcome of STEMI by primary angioplasty, and to identify any potential category of patients at risk for delay to treatment or no presentation.

NCT04412655 ST Elevated Myocardial Infarction Undergoing Mechanical Reperfusion Device: Percutaneous Coronary Revascularization for STEMI
MeSH:Myocardial Infarction ST Elevation Myocardial Infarction Infarction
HPO:Myocardial infarction

Primary Outcomes

Description: Number of patients undergoing primary angioplasty

Measure: Number of patients undergoing primary angioplasty

Time: March April 2019 and 2020

Description: Number of patients undergoing primary angioplasty later 12 hours from symptoms onset;

Measure: Number of patients undergoing primary angioplasty later than 12 hours from symptoms onset;

Time: March April 2019 and 2020

Description: Number of patients undergoing primary angioplasty later than 30 minutes from PCI hospital admission

Measure: Number of patients undergoing primary angioplasty later than 30 minutes from PCI hospital admission

Time: March April 2019 and 2020

Description: In-Hospital mortality

Measure: In-hospital mortality

Time: March April 2019 and 2020


Related HPO nodes (Using clinical trials)